FR2765580B1 - Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique - Google Patents

Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique

Info

Publication number
FR2765580B1
FR2765580B1 FR9708256A FR9708256A FR2765580B1 FR 2765580 B1 FR2765580 B1 FR 2765580B1 FR 9708256 A FR9708256 A FR 9708256A FR 9708256 A FR9708256 A FR 9708256A FR 2765580 B1 FR2765580 B1 FR 2765580B1
Authority
FR
France
Prior art keywords
imidazol
preparation
therapeutic application
piperidine derivatives
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9708256A
Other languages
English (en)
Other versions
FR2765580A1 (fr
Inventor
Gerard Cremer
Christian Hoornaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9708256A priority Critical patent/FR2765580B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to EP98932236A priority patent/EP0994857A1/fr
Priority to AU82205/98A priority patent/AU8220598A/en
Priority to PCT/FR1998/001287 priority patent/WO1999001435A1/fr
Priority to JP50651199A priority patent/JP2002507983A/ja
Priority to ZA985727A priority patent/ZA985727B/xx
Priority to ARP980103161A priority patent/AR013149A1/es
Publication of FR2765580A1 publication Critical patent/FR2765580A1/fr
Application granted granted Critical
Publication of FR2765580B1 publication Critical patent/FR2765580B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9708256A 1997-07-01 1997-07-01 Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique Expired - Fee Related FR2765580B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9708256A FR2765580B1 (fr) 1997-07-01 1997-07-01 Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
AU82205/98A AU8220598A (en) 1997-07-01 1998-06-19 (1h-imidazol-4-yl)piperidine derivatives, preparation and application in therapy
PCT/FR1998/001287 WO1999001435A1 (fr) 1997-07-01 1998-06-19 Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
JP50651199A JP2002507983A (ja) 1997-07-01 1998-06-19 （１ｈ−イミダゾール−４−イル）ピペリジン誘導体、それらの製造およびそれらの治療における応用
EP98932236A EP0994857A1 (fr) 1997-07-01 1998-06-19 DERIVES DE (1$i(H)-IMIDAZOL-4-YL)PIPERIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
ZA985727A ZA985727B (en) 1997-07-01 1998-06-30 (1H-imidazol-4-YL) piperidine derivatives their preparation and their application in therapeutics
ARP980103161A AR013149A1 (es) 1997-07-01 1998-06-30 Derivados de (1h-imidazol-4-il)piperidina, su preparacion y su aplicacion en terapeutica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708256A FR2765580B1 (fr) 1997-07-01 1997-07-01 Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2765580A1 FR2765580A1 (fr) 1999-01-08
FR2765580B1 true FR2765580B1 (fr) 1999-08-06

Family

ID=9508676

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9708256A Expired - Fee Related FR2765580B1 (fr) 1997-07-01 1997-07-01 Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique

Country Status (7)

Country Link
EP (1) EP0994857A1 (fr)
JP (1) JP2002507983A (fr)
AR (1) AR013149A1 (fr)
AU (1) AU8220598A (fr)
FR (1) FR2765580B1 (fr)
WO (1) WO1999001435A1 (fr)
ZA (1) ZA985727B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
GB0011089D0 (en) 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (11)
TW200614995A (en) 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357341A (en) * 1981-05-22 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Specific irreversible antagonism of histamine receptors by photoaffinity actuated compounds
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
JP2002507983A (ja) 2002-03-12
ZA985727B (en) 1999-01-27
AU8220598A (en) 1999-01-25
FR2765580A1 (fr) 1999-01-08
WO1999001435A1 (fr) 1999-01-14
EP0994857A1 (fr) 2000-04-26
AR013149A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
MA22981A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique.
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2772377B1 (fr) Derives de 1-(1-h-imidazol-2-yl)pyrrolidines et 1-(1-h-imidazol-2-ylpiperidines), leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2765582B1 (fr) Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2765580B1 (fr) Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2738567B1 (fr) Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique
FR2724383B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse